Close but no cigar for Allergan, Inc. (NYSE: AGN), considering it missed the billion-dollar mark with its $958 million acquisition for MAP Pharmaceuticals, Inc. (NASDAQ: MAPP). Or perhaps the global health care giant deserves a cigar after all, for buying the...
Brought to you by www.DealSearchOnline.com February 11, 2013 Issue: Recent Health Care M&A Deals Spotlight On: Biotechnology Spotlight on: E-Health Webcast Calendar Recent Health Care M&A Deals BIOTECHNOLOGY Acquirer Target Price Biogen Idec, Inc....
Being profitable doesn’t make a division all that valuable, it appears. In the wake of its $3.72 billion acquisition of Gen-Probe (NASDAQ: GPRO) last year, Hologic, Inc. (NASDAQ: HOLX) began cleaning house in order to pay its debts. One result: Immucor, Inc. agreed to...
M&A Activity Goes Off the Fiscal Cliff in January The equity markets are staging their own version of a mid-winter comeback, with the Dow dancing around the 14,000 mark for the first time in five years. That would certainly seem to presage a similar rise in...
The Sector Gears Up for Growth in 2013 Dealmaking in the behavioral health care sector has picked up in recent years, thanks to a number of factors and despite a few others. Last year, we recorded 17 transactions, up slightly from 15 deals announced in 2011. Four...
Brought to you by www.DealSearchOnline.com February 4, 2013 Issue: Recent Health Care M&A Deals Spotlight On: Pharmaceuticals Spotlight on: Medical Devices Webcast Calendar Recent Health Care M&A Deals HOSPITALS Acquirer Target Price Bangkok Dusit...